Targeting metabotropic glutamate receptors for novel treatments of schizophrenia. - Wikidata - awgldk - TriplyDB

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

http://www.wikidata.org/entity/Q33604654

about

Control of neuronal excitability by Group I metabotropic glutamate receptors.Brain-Specific SNAP-25 Deletion Leads to Elevated Extracellular Glutamate Level and Schizophrenia-Like Behavior in Mice.Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction.Age-Related Declines in Prefrontal Cortical Expression of Metabotropic Glutamate Receptors that Support Working Memory.Schizophrenia: synthetic strategies and recent advances in drug design Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression

P2860

Q46083239-6DBE7E30-EF77-4DC0-81D5-2799F79BCDB8 Q47215283-EA8108ED-709A-44DF-900A-1E0ED2E752A8 Q47663907-665E08E8-DDB5-4C26-8808-43EB66028683 Q55406147-49981E9A-DA78-4DD3-96E5-6EF303D425A4 Q57393544-03B8C7A0-96A6-45B9-BE35-B8E872BAACF3 Q57816814-969C6244-71B3-46A8-B35E-E3F332719C11 Q58737944-582EC7C5-ED7E-4254-8094-D257BF81E142

P2860

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

http://www.wikidata.org/entity/Q33604654

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

@ast

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

@en

type

label

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

@ast

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

@en

prefLabel

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

@ast

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

@en

P1433

Q33604654-42F89B58-402E-45B9-81BF-AA4D9B1EC994

P1476

Q33604654-19629DE5-B8A5-452C-A0FB-7367F15C63AE

P2093

Q33604654-5308C10B-DFD5-4CB8-978D-A9C37A21E738

Q33604654-F0BCF585-3E06-43D2-B156-F25A89B5DA8A

P275

Q33604654-5480D917-1620-4A58-9B5B-40A50395AF7F

P2860

Q33604654-00CF4F13-8AE9-4C54-A4F0-3A0F71F26EB1

Q33604654-0104AC85-0BA8-4CE0-BE09-2A1928E369CF

Q33604654-01751847-E06C-4210-A7DD-72B53A0407E7

Q33604654-01954B07-8763-4F92-A6A4-415242575769

Q33604654-01FF24DF-DFE4-448F-9E19-151A6E920B23

Q33604654-0217F130-A8CF-4EBB-BF06-878D40E542CD

Q33604654-03D2DF04-37D6-4536-984A-817A5551614B

Q33604654-052BFA2D-9CE2-4952-B5B4-655C79EAC89C

Q33604654-09270F84-9CDC-4295-B243-79654D68F8BA

Q33604654-096C4024-CFAA-4F0C-A15C-E6E749317CD7

P2888

Q33604654-5D6C2162-1417-4772-A76E-1A91D691E0E8

P304

Q33604654-58A251CE-0E47-42B6-AA88-1456178F432C

P31

Q33604654-7795BAA0-2010-4D6D-A02C-D882BCD5EC66

Q33604654-B6E7997E-E5B2-4AE7-B08B-49A7E613AC4D

P356

Q33604654-E666BCD1-033A-48BE-8196-F2721675A444

P433

Q33604654-6FEF8CAC-2FF3-499F-90C8-9DE87727C378

P478

Q33604654-85DB62BD-309B-4AAA-8011-AC9454F96D6C

P50

Q33604654-3EB41009-C945-43BC-94DD-A12D21869B48

P577

Q33604654-C28FB439-BAB4-4FEB-9E51-72BB83A12A66

P6179

Q33604654-EFCDC547-AB9A-4729-9D40-CD115F41CF54

P698

Q33604654-3FCB8890-3ED3-471C-8122-EAB39F291C15

P921

Q33604654-5A0CE763-9EAC-495A-88CE-6D5FA2FCB3D6

Q33604654-8563F3F4-08F8-4784-84C3-2E44D8F75C72

Q33604654-86090BAB-B137-43E0-9D1A-81719F0819D8

P932

Q33604654-46CFB8A4-9E18-42E2-B620-835E188653F2

P356

S13041-017-0293-Z

P1433

Molecular Brain

P1476

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

@en

P2093

James Maksymetz

http://www.w3.org/2001/XMLSchema#string

Sean P Moran

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

Long-Term Potentiation and Memory

(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord

A prolyl-isomerase mediates dopamine-dependent plasticity and cocaine motor sensitization

Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator

Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site

Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics

Biological insights from 108 schizophrenia-associated genetic loci

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia

Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS

P2888

s13041-017-0293-z

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13041-017-0293-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084955711

http://www.w3.org/2001/XMLSchema#string

P698

28446243

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

membrane proteins

P932

5405554

http://www.w3.org/2001/XMLSchema#string